carlisle & Associates
generic drug updates News contact carlisle medical
generic drug updates
Generic Bactroban® Launches
Released: 01/28/2013
By: Mike Partridge, RPh

On January 25, 2013, Glenmark received final FDA approval for and commenced shipping the generic equivalent for GlaxoSmithKline’s branded product, Bactroban® (mupirocin) cream. Bactroban® had estimated total U.S. annual sales of approximately $70 million.
Bactroban is indicated for the treatment of secondarily infected traumatic skin lesions due to susceptible strains of S. aureus and S. pyogenes.

Company News Releases
Generic Drug Updates
Newsletter Subscription
Newsletter Login
© Copyright 2019 Carlisle Medical, Inc.
Twitter Twitter Twitter Twitter
disclaimer site map disclaimer